Have a personal or library account? Click to login
Prognostic Value of CYP1A2 (rs2069514 and rs762551) Polymorphisms in COVID-19 Patients Cover

Prognostic Value of CYP1A2 (rs2069514 and rs762551) Polymorphisms in COVID-19 Patients

By: I Bozkurt,  T Gözler,  I Yüksel,  K Ulucan and  KN Tarhan  
Open Access
|Jul 2023

Figures & Tables

Distributions of CYP1A2 rs2069514 and rs762551 polymorphisms by ICU and Mortality Status

Intensive CareMortality
Non = 35Yesn = 25Aliven = 47Exn = 13
CYP1A2 (rs2069514)Genotype n (%)AA2 (5.7)4 (16.0)3 (6.4)3 (23.1)
AG3 (8.6)11 (44.0)7 (14.9)7 (53.8)
GG30 (85.7)10 (40.0)37 (78.7)3 (23.1)
Allele frequency, n (%)A11 (14.8)19 (38.0)13 (13.8)13 (50.0)
G63 (85.2)31 (62.0)81 (86.2)13 (50.0)
CYP1A2 (rs762551)Genotype n (%)AA16 (45.7)5 (20.0)18 (38.3)3 (23.1)
AC10 (28.6)5 (20.0)12 (25.5)3 (23.1)
CC9 (25.7)15 (60.0)17 (36.2)7 (53.8)
Allele frequency, n (%)A42 (59.9)15 (30,0)48 (51.1)9 (34.6)
C28 (40.1)35 (70.0)46 (48.9)17 (65.4)

Distribution of age, gender, additional disease, and symptom information of patients with COVID-19 (n=60)

Variables N (%)
Age<6529 (48.3)
≥6531 (51.7)
GenderMale32 (53.3)
Female28 (46.7)
Chronic DiseaseNo38 (63.3)
Yes22 (36.7)
Cardiovascular DiseaseNo47 (78.3)
Yes13 (21.7)
Respiratory DistressNo39 (65.0)
Yes21 (35.0)
Neurological DiseaseNo54 (90.0)
Yes6 (10.0)
FeverNo50 (83.3)
Yes10 (16.7)
FatigueNo33 (55.0)
Yes27 (45.0)
CoughNo37 (61.7)
Yes23 (38.3)
Loss of Taste and SmellNo50 (83.3)
Yes10 (16.7)
DiarrheaNo59 (98.3)
Yes1 (1.7)
Nausea VomitingNo56 (93.3)
Yes4 (6.7)
IntubatedNo45 (75.0)
Yes15 (25.0)
ExpectorationNo60 (100.0)
Yes0 (0,0)
Frosted Glass ImageNo40 (66.7)
Yes20 (33.3)
MortalityAlive47 (78.3)
Ex13 (21.7)
Intensive CareAlive35 (58.3)
Passed away25 (41.7)

Comparison of patients with and without intensive care

Intensive Care Hospitalization
Parameters, n (%)Yesn = 25Non = 35p
Age
  <655 (17.2)24 (82.8)<0.001a
  ≥6520 (64.5)11 (35.5)
Gender
  Male15 (60.0)17 (48.6)0.382a
  Woman10 (40.0)18 (51.4)
Chronic Disease
  No10 (26.3)28 (73.7)0.002a
  Yes15 (68.2)7 (31.8)
Cardiovascular Disease
  No15 (31.9)32 (68.1)0.004a
  Yes10 (76.9)3 (23.1)
Respiratory Distress
  No5 (12.8)34 (87.2)<0.001a
  Yes20 (95.2)1 (4.8)
Neurological Disease
  No19 (35.2)35 (64.8)0.004b
  Yes6 (100.0)0 (0,0)
Fever
  No20 (40.0)30 (60.0)0.558b
  Yes5 (50.0)5 (50.0)
Cough
  No13 (35.1)24 (64.9)0.193a
  Yes12 (52.2)11 (47.8)
Weakness
  No10 (30.3)23 (69.7)0.048a
  Yes15 (55.6)12 (44.4)
Loss of Taste and Smell
  No25 (50.0)25 (50.0)0.003b
  Yes0 (0,0)10 (100.0)
Diarrhea
  No24 (40.7)35 (59.3)0.417b
  Yes1 (100.0)0 (0,0)
Nausea Vomiting
  No21 (37.5)35 (62.5)0.026b
  Yes4 (100.0)0 (0,0)
Intubated
  No10 (22.2)35 (77.8)<0.001a
  Yes15 (100.0)0 (0,0)
Frosted Glass Image
  No6 (15.0)34 (85.0)<0.001a
  Yes19 (95.0)1 (5.0)
CYP1A2 rs2069514
  GG10 (25.0)30 (75.0)<0.001a
  AA+AG15 (75.0)5 (25.0)
CYP1A2 rs762551
  AA5 (23.8)16 (76.2)0.040a
  CC+CA20 (51.3)19 (48.7)
CYP1A2 Genotype
  *1A/*1A5 (55.6)4 (44.4)<0.001a
  *1A/*1F+*1F/*1F5 (16.1)26 (83.9)
  *1C/*1F4 (100.0)0 (0,0)
  *1A/*1C+*1C/*1C11 (68.8)5 (31.3)

Multivariate Logistic Regression Results on ICU Admission for Various Variables_

Multivariate
VariablesOR (95%CI)p
CYP1A2 Genotype (ref: *1A/*1A+*1F/*1F)5.23 (1.22–22.36)0.025
Chronic disease (ref: none)4.68 (1.14–19.15)0.032
Fatigue (ref: none)0.92 (0.21–3.94)0.920
Age (ref: <65)5.17 (1.26–21.14)0.022
R2 =0.48 −2 Log likelihood =55.201
Language: English
Page range: 35 - 42
Published on: Jul 31, 2023
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2023 I Bozkurt, T Gözler, I Yüksel, K Ulucan, KN Tarhan, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.